MECURE Stock Overview
Mecure Industries PLC manufactures and sells pharmaceuticals and nutraceuticals in Nigeria.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Mecure Industries PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦9.72 |
| 52 Week High | ₦13.00 |
| 52 Week Low | ₦6.30 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -10.00% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 69.63% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MECURE | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | -0.6% |
| 1Y | n/a | 13.6% | 115.7% |
Return vs Industry: Insufficient data to determine how MECURE performed against the NG Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how MECURE performed against the NG Market.
Price Volatility
| MECURE volatility | |
|---|---|
| MECURE Average Weekly Movement | 2.9% |
| Pharmaceuticals Industry Average Movement | 3.9% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in NG Market | 11.9% |
| 10% least volatile stocks in NG Market | 3.4% |
Stable Share Price: MECURE has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MECURE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Anderline Dukor | www.mecure.com |
Mecure Industries PLC manufactures and sells pharmaceuticals and nutraceuticals in Nigeria. The company develops, produces, and markets generic drugs, as well as specialty pharmaceuticals. It offers tablets, capsules and syrups; and multivitamins and dietary supplements.
Mecure Industries PLC Fundamentals Summary
| MECURE fundamental statistics | |
|---|---|
| Market cap | ₦38.88b |
| Earnings (TTM) | ₦0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MECURE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MECURE income statement (TTM) | |
|---|---|
| Revenue | ₦0 |
| Cost of Revenue | ₦0 |
| Gross Profit | ₦0 |
| Other Expenses | ₦0 |
| Earnings | ₦0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MECURE perform over the long term?
See historical performance and comparison